C12N 2760/20051
Methods of production or purification of viral material
C12N2760/20051 (Methods of production or purification of viral material) appears on 13 US grants and 17 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 17
- Assignees
- 12
- Inventors
- 35
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 3 | 1 |
| 2020 | 2 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 2 | 4 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Antioxidant culture method and antioxidant auxiliary equipment11 Aug 2026US 12,703,924 B2National Pingtung University of Science and Technology
- Methods of detection and removal of rhabdoviruses from cell lines25 Nov 2025US 12,479,891 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines25 Jun 2024US 12,018,052 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines11 Jun 2024US 12,006,341 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines29 Mar 2022US 11,286,282 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines30 Jul 2026US 2026/0217770 A1Takeda Vaccines, Inc.
- Methods and compositions of virus-like particles of cytoplasmic type citrus leprosis virus for nanotechnology applications2 Oct 2025US 2025/0304922 A1The Regents of the University of California
- Methods of detection and removal of rhabdoviruses from cell lines3 Apr 2025US 2025/0109172 A1Takeda Vaccines, Inc.
- Artificial oncolytic viruses and related methods11 Jul 2024US 2024/0226208 A9Humane Genomics
- Recombinant viral expression vectors and methods of use6 Jun 2024US 2024/0182916 A1North Carolina State University
Most cited
By later US patents
- Methods of detection and removal of rhabdoviruses from cell lines4US 10,501,500 B2Takeda Vaccines, Inc. · 2019
- Methods of detection and removal of rhabdoviruses from cell lines3US 11,286,282 B2Takeda Vaccines, Inc. · 2022
- Marker system, in particular for baculovirus-expressed subunit antigens1US 10,168,330 B2Boehringer Ingelheim Vetmedica GmbH · 2019
- Bioreactor production of virus from adherent cells1US 10,851,350 B1Genelux Corporation · 2020
- Methods of detection and removal of rhabdoviruses from cell lines1US 12,006,341 B2Takeda Vaccines, Inc. · 2024